Vincent Medical Holdings Limited (HKG:1612)
Hong Kong · Delayed Price · Currency is HKD 0.6650
-0.0050 (-0.75%)
Sep 11, 2026, 3:56 PM HKT
Vincent Medical Holdings Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 964.9 | 932.78 | 800.96 | 717.97 | 629.24 | 777.72 | |
Revenue Growth | 10.95% | 16.46% | 11.56% | 14.10% | -19.09% | -32.69% |
Cost of Revenue | 631.16 | 605.34 | 540.97 | 477.59 | 463.89 | 518.62 |
Gross Profit | 333.74 | 327.44 | 259.99 | 240.39 | 165.35 | 259.1 |
Selling, General & Admin | 154.17 | 149.31 | 151.2 | 138 | 133.65 | 125.42 |
Research & Development | 53.5 | 48.74 | 30.6 | 36.06 | 36.68 | 39.25 |
Other Operating Expenses | -3.57 | -3.91 | -2.24 | -0.64 | -3.44 | 7.24 |
Operating Expenses | 203.19 | 193.44 | 182.18 | 174.51 | 166.89 | 171.9 |
Operating Income | 130.55 | 134.01 | 77.82 | 65.88 | -1.54 | 87.2 |
Interest Expense | -2.88 | -0.9 | -1.36 | -1.68 | -2.85 | -2.43 |
Interest & Investment Income | 1.3 | 1.3 | 1.2 | 0.7 | 0.51 | 0.38 |
Earnings From Equity Investments | 1.05 | 0.84 | -0.33 | 2.82 | -1.66 | -5.88 |
Currency Exchange Gain (Loss) | -7.06 | 1.94 | 2.87 | 0.48 | -5.77 | 0.81 |
EBT Excluding Unusual Items | 122.96 | 137.2 | 80.2 | 68.2 | -11.31 | 80.08 |
Gain (Loss) on Sale of Investments | -1 | -1 | -1.15 | -1.66 | -3.82 | -10.73 |
Gain (Loss) on Sale of Assets | - | - | - | 0.45 | 0.62 | -2.26 |
Asset Writedown | -2.7 | -6.56 | -1.07 | -0.08 | -1.01 | -0.92 |
Pretax Income | 119.26 | 129.64 | 77.98 | 66.92 | -15.52 | 66.18 |
Income Tax Expense | 20.3 | 21.29 | 7.08 | 8.71 | 2.87 | 6.11 |
Earnings From Continuing Operations | 98.96 | 108.35 | 70.9 | 58.21 | -18.39 | 60.07 |
Minority Interest in Earnings | -2.67 | -3.97 | -1.73 | -0.93 | 0.99 | 0.63 |
Net Income | 96.3 | 104.38 | 69.17 | 57.28 | -17.4 | 60.7 |
Net Income to Common | 96.3 | 104.38 | 69.17 | 57.28 | -17.4 | 60.7 |
Net Income Growth | 10.04% | 50.91% | 20.76% | - | - | -72.01% |
Shares Outstanding (Basic) | 648 | 645 | 643 | 646 | 654 | 654 |
Shares Outstanding (Diluted) | 649 | 645 | 643 | 646 | 654 | 661 |
Shares Change | 0.87% | 0.27% | -0.36% | -1.24% | -1.12% | 1.49% |
EPS (Basic) | 0.15 | 0.16 | 0.11 | 0.09 | -0.03 | 0.09 |
EPS (Diluted) | 0.15 | 0.16 | 0.11 | 0.09 | -0.03 | 0.09 |
EPS Growth | 9.11% | 50.51% | 21.20% | - | - | -72.42% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -26.68 | 53.48 | -20.98 | 93.34 | 57.16 | 94.1 |
Free Cash Flow Per Share | -0.04 | 0.08 | -0.03 | 0.14 | 0.09 | 0.14 |
Dividend Per Share | 0.046 | 0.050 | 0.033 | 0.028 | - | 0.045 |
Dividend Growth | 12.20% | 51.52% | 20.00% | - | - | -59.09% |
Gross Margin | 34.59% | 35.10% | 32.46% | 33.48% | 26.28% | 33.32% |
Operating Margin | 13.53% | 14.37% | 9.71% | 9.18% | -0.24% | 11.21% |
Profit Margin | 9.98% | 11.19% | 8.63% | 7.98% | -2.77% | 7.80% |
Free Cash Flow Margin | -2.77% | 5.73% | -2.62% | 13.00% | 9.09% | 12.10% |
EBITDA | 156.38 | 155.33 | 99.6 | 88.07 | 22.21 | 111.65 |
EBITDA Margin | 16.21% | 16.65% | 12.43% | 12.27% | 3.53% | 14.36% |
D&A For EBITDA | 25.84 | 21.32 | 21.78 | 22.19 | 23.74 | 24.44 |
EBIT | 130.55 | 134.01 | 77.82 | 65.88 | -1.54 | 87.2 |
EBIT Margin | 13.53% | 14.37% | 9.71% | 9.18% | -0.24% | 11.21% |
Effective Tax Rate | 17.02% | 16.42% | 9.08% | 13.01% | - | 9.23% |